FRAZIER MANAGEMENT LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$33,362,000
-49.4%
1,747,622
-34.7%
2.57%
-51.3%
Q3 2021$65,948,000
+18.5%
2,674,299
+25.1%
5.28%
+2.9%
Q2 2021$55,631,000
+33.8%
2,137,999
+62.8%
5.13%
+53.9%
Q1 2021$41,570,000
-31.8%
1,312,9990.0%3.33%
-28.9%
Q4 2020$60,923,000
+40.9%
1,312,9990.0%4.69%
+20.9%
Q3 2020$43,224,000
+19.9%
1,312,9990.0%3.88%
+22.6%
Q2 2020$36,042,000
-31.2%
1,312,999
-25.0%
3.16%
-46.7%
Q1 2020$52,406,000
+8.1%
1,750,6650.0%5.94%
-26.9%
Q4 2019$48,458,000
+52.1%
1,750,6650.0%8.13%
-18.4%
Q3 2019$31,862,000
-40.6%
1,750,665
-20.0%
9.96%
-27.5%
Q2 2019$53,658,000
+157.8%
2,188,3310.0%13.75%
+174.4%
Q1 2019$20,811,000
+7.5%
2,188,3310.0%5.01%
+0.3%
Q4 2018$19,367,000
-21.3%
2,188,3310.0%5.00%
+10.8%
Q3 2018$24,619,000
-12.1%
2,188,3310.0%4.51%
-22.3%
Q2 2018$28,011,000
-24.3%
2,188,3310.0%5.80%
-5.5%
Q1 2018$36,983,000
+111.2%
2,188,3310.0%6.14%
+116.2%
Q4 2017$17,507,000
+3.2%
2,188,3310.0%2.84%
-53.1%
Q3 2017$16,960,000
+11.5%
2,188,3310.0%6.05%
-22.4%
Q2 2017$15,209,0002,188,3317.80%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Perceptive Advisors 11,826,299$130,562,0004.09%
MPM BioImpact LLC 1,200,000$13,248,0003.68%
Finepoint Capital LP 960,200$10,601,0003.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,011$273,000,0002.85%
Avoro Capital Advisors LLC 9,220,000$101,789,0002.01%
Long Focus Capital Management, LLC 1,625,000$17,940,0001.88%
683 Capital Management, LLC 2,000,000$22,080,0001.56%
Parametrica Management Ltd 115,870$1,268,0001.38%
Boxer Capital, LLC 1,935,133$21,364,0001.35%
Soleus Capital Management, L.P. 719,600$7,944,0001.24%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders